uniQure N.V. Ordinary Shares (QURE) Stock
NASDAQ · QURE
44.31
Fundamentals
Market cap
$3.05B
Price / Earnings ratio
-12.1x
Price / Sales ratio
163.5x
Price / Book ratio
9.4x
Return on assets
-0.3%
Ex-Dividend date
N/A
Last payment date
N/A
Dividend amount
$0.00
Dividend yield
0.0%
Debt / Equity ratio
N/A
Latest news
About uniQure N.V. Ordinary Shares
No description available.
SectorHealthcare
IndustryBiotechnology
Employees221
CEOMr. Matthew Craig Kapusta CPA
IPO DateFeb 5, 2014
HeadquartersAmsterdam, Netherlands
Key Executives
| Name | Title | Year Born |
|---|---|---|
| Mr. Matthew Craig Kapusta CPA | CEO & Executive Director | 1972 |
| Mr. Christian Klemt | CFO, Principal Financial Officer & GM of Amsterdam Site | 1973 |
| Dr. Jeannette Potts J.D., Ph.D. | Chief Legal & Compliance Officer and Corporate Secretary | 1962 |
| Dr. Walid Abi-Saab M.D. | Chief Medical Officer | 1965 |
| Prof. Hugo Katus | Chairman of Scientific Advisory Board and Managing Director of UniQure-Germany | — |
| Dr. Amin Abujoub Ph.D. | Chief Technical Operations Officer | — |
| Mr. Richard Porter Ph.D. | Chief Business & Scientific Officer | 1968 |
| Ms. Chiara Elizabeth Russo | Senior Director of Investor Relations | — |
| Dr. Tamara Tugal Ph.D., MBA | Business Development Director | — |
| Ms. Erin Boyer | Chief People & Culture Officer | — |
Fundamentals
Valuation
Market cap$3.05B
Price-to-sales ratio163.46
Price-to-book value9.42
Price-earnings ratio-12.10
Return on Equity-146.00%
Return on SalesN/A
Return on AssetsN/A
PEG ratio0.00
Earnings Per Share
Earnings Per Share$-4.01
Income Statement
Average volume1,235,515
EBITDA$-129.14M
1 year high (52w)$71.50
1 year low (52w)$8.73
Dividend
Ex dividend dateN/A
Dividend amount$0.00
Dividend yield0.00%
Last payment dateN/A
Dividend yield (TTM)N/A
Next earnings reportN/A
Solvency
Debt-to-equity ratioN/A



